|Bid||118.89 x 1100|
|Ask||119.29 x 800|
|Day's Range||117.00 - 119.98|
|52 Week Range||49.80 - 128.59|
|Beta (3Y Monthly)||1.69|
|PE Ratio (TTM)||46.18|
|Earnings Date||Nov 5, 2018 - Nov 9, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||125.90|
Zacks.com highlights: Robert Half International, Children's Place, Amedisys, Foot Locker and Comfort Systems USA
Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on November 14. Index (PMI) data, output in the Healthcare sector is rising.
Amedisys stock is the IBD Stock Of The Day as the medical sector name looks to form a new buy point after finding support at the 50-day line.
With the markets currently facing a lot of gyration, investing in quality stocks seems prudent. After all, these stocks provide excellent risk-adjusted returns.
Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on November 9. Index (PMI) data, output in the Healthcare sector is rising.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Zacks.com highlights: Core-Mark Holding, CACI International, Amedisys, Cadence Design Systems and WNS Holdings
The Zacks Analyst Blog Highlights: Archer-Daniels-Midland, Best Buy, Heidrick & Struggles International, Amedisys and RH
With November all set to dispel the darkness of October, investing in fundamentally sound stocks that are poised to gain in the near term seems judicious.
NEW YORK, NY / ACCESSWIRE / October 31, 2018 / Shares of Electro Scientific Industries was soaring on Tuesday as the company reported second quarter results and announced that it would be acquired by MKS Instruments for $1 billion. Shares of Amedisys was also in the green after reporting solid third quarter results. Electro Scientific Industries, Inc. shares closed up about 91% on Tuesday with around 13.2 million shares traded.
At the Home Health and Hospice divisions, Amedisys (AMED) gains traction from solid growth in Medicare and non-Medicare revenues in Q3.
Amedisys (AMED) delivered earnings and revenue surprises of 23.38% and 1.74%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The Baton Rouge, Louisiana-based company said it had net income of 96 cents per share. Earnings, adjusted for non-recurring gains, came to 95 cents per share. The results topped Wall Street expectations. ...
BATON ROUGE, La., Oct. 29, 2018 -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month period ended September 30, 2018. Three Month.
Today I will be providing a simple run through of a valuation method used to estimate the attractiveness of Amedisys Inc (NASDAQ:AMED) as an investment opportunity by taking the expected Read More...
Amedisys' (AMED) Q3 is anticipated to benefit from a strong uptick across all its three business lines consisting of Home Health, Hospice and Personal Care.